Home > Insider Trading > Filing (0001415889-24-006792)

Filing Details

Accession Number:: 0001415889-24-006792
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-03-05 17:30:50
Reporting Period:: 2024-03-01

Accepted Time:: 2024-03-05 17:30:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1551152	Abbvie Inc.	ABBV	Pharmaceutical Preparations (2834)	320375147

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1563523	J. Timothy Richmond	1 N. Waukegan Road North Chicago IL 60064	Evp, Chief Hr Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $0.01 Par Value	Acquisiton	2024-03-01	45,700	$61.36	89,517	No	4	M	Direct
Common Stock, $0.01 Par Value	Disposition	2024-03-01	15,412	$176.40	74,105	No	4	S	Direct
Common Stock, $0.01 Par Value	Disposition	2024-03-01	30,288	$177.71	43,817	No	4	S	Direct
Common Stock, $0.01 Par Value	Disposition	2024-03-01	9,853	$176.35	33,964	No	4	S	Direct
Common Stock, $0.01 Par Value	Disposition	2024-03-01	20,127	$177.71	13,837	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (Right to buy)	Disposition	2024-03-01	45,700	$61.36	45,700	$61.36

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2018-02-16	2027-02-15	No	4	M	Direct

Footnotes

This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 13, 2023.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.76 to $176.72, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
he price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.77 to $177.36, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.76 to $176.69, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.72 to $177.36, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.